Literature DB >> 11891429

Vascular genomics of the human brain.

Eric V Shusta1, Ruben J Boado, Gary W Mathern, William M Pardridge.   

Abstract

The microvasculature of the human brain plays an important role in the development and maintenance of the central nervous system and in the pathogenesis of brain diseases, and is the site of differential gene expression within the brain. However, human brain microvascular-specific genes may not be detected in whole-brain gene microarray because the volume of the brain microvascular endothelium is relatively small (0.1%) compared with the whole brain. Therefore, the differential gene expression within the human brain microvasculature was evaluated using suppression subtractive hybridization with RNA isolated from human brain microvessels. Gene identification was restricted to the first 71 clones that were differentially expressed at the brain microvasculature. Twenty of these were genes encoding proteins with known function that were involved in angiogenesis, neurogenesis, molecular transport, and maintenance of endothelial tight junctions or the cytoskeleton. Eighteen genes coding for proteins of an unknown function were identified, including five genes containing satellite DNA sequences. The results provide the initial outline of the genomics of the human brain microvasculature, and have implications for the identification of both targets for brain-specific drug transport and changes in microvascular gene expression in brain diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891429     DOI: 10.1097/00004647-200203000-00001

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  16 in total

Review 1.  Blood-brain barrier genomics, proteomics, and new transporter discovery.

Authors:  Eric V Shusta
Journal:  NeuroRx       Date:  2005-01

Review 2.  Molecular biology of the blood-brain barrier.

Authors:  William M Pardridge
Journal:  Mol Biotechnol       Date:  2005-05       Impact factor: 2.695

3.  A genomic comparison of in vivo and in vitro brain microvascular endothelial cells.

Authors:  Anthony R Calabria; Eric V Shusta
Journal:  J Cereb Blood Flow Metab       Date:  2007-06-13       Impact factor: 6.200

Review 4.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

5.  An innovative strategy to identify new targets for delivering antibodies to the brain has led to the exploration of the integrin family.

Authors:  Céline Cegarra; Béatrice Cameron; Catarina Chaves; Tarik Dabdoubi; Tuan-Minh Do; Bruno Genêt; Valérie Roudières; Yi Shi; Patricia Tchepikoff; Dominique Lesuisse
Journal:  PLoS One       Date:  2022-09-15       Impact factor: 3.752

6.  Transcriptomic screening of microvascular endothelial cells implicates novel molecular regulators of vascular dysfunction after spinal cord injury.

Authors:  Richard L Benton; Melissa A Maddie; Christopher A Worth; Edward T Mahoney; Theo Hagg; Scott R Whittemore
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-09       Impact factor: 6.200

7.  Identification and expression profiling of blood-brain barrier membrane proteins.

Authors:  Nitin Agarwal; Ethan S Lippmann; Eric V Shusta
Journal:  J Neurochem       Date:  2009-11-06       Impact factor: 5.372

8.  Identifying blood-brain-barrier selective single-chain antibody fragments.

Authors:  Angela R Jones; C Christopher Stutz; Yu Zhou; James D Marks; Eric V Shusta
Journal:  Biotechnol J       Date:  2014-03-18       Impact factor: 4.677

Review 9.  Combinatorial approaches for the identification of brain drug delivery targets.

Authors:  Charles C Stutz; Xiaobin Zhang; Eric V Shusta
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

10.  TNAP and EHD1 are over-expressed in bovine brain capillary endothelial cells after the re-induction of blood-brain barrier properties.

Authors:  Barbara Deracinois; Sophie Duban-Deweer; Gwënaël Pottiez; Roméo Cecchelli; Yannis Karamanos; Christophe Flahaut
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.